HOME › DRUGS › AUTOLOGOUS PERIPHERAL-BLOOD MONONUCLEAR CELLS ACTIVATED WITH PROSTATIC ACID PHOSPHATASE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (SIPULEUCEL-T)
ACTIVE SUBSTANCE / INN

AUTOLOGOUS PERIPHERAL-BLOOD MONONUCLEAR CELLS ACTIVATED WITH PROSTATIC ACID PHOSPHATASE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (SIPULEUCEL-T)

Brand name(s): Provenge
EMA LISTED
WITHDRAWN
Prostatic Neoplasms
ACTIVE SUBSTANCE
Autologous Peripheral-Blood Mononuclear Cells Activated With Prostatic Acid Phosphatase Granulocyte-Macrophage Colony-Stimulating Factor (Sipuleucel-T)
REGULATORS
EMA
SPONSORS / MAH
Dendreon UK Ltd
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ProvengeDendreon UK LtdWithdrawn06/09/2013Prostatic Neoplasms

FULL INTELLIGENCE ON AUTOLOGOUS PERIPHERAL-BLOOD MONONUCLEAR CELLS ACTIVATED WITH PROSTATIC ACID PHOSPHATASE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (SIPULEUCEL-T)

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →